Binh Dinh Pharmaceutical & Medical Equipment JSC

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DBD0
VND
49,000.00
-500 (-1.01%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
4,74,537.02
4,41,045.05
4,77,900.91
4,32,818.33
4,33,050.49
3,83,778.67
4,44,495.27
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,74,537.02
4,41,045.05
4,77,900.91
4,32,818.33
4,33,050.49
3,83,778.67
4,44,495.27
Raw Material Cost
2,35,186.46
2,15,971.16
2,64,714.19
2,21,693.65
2,23,194.03
1,98,538.86
2,45,892.42
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1,10,682.36
98,358.93
74,735.84
92,396.43
88,854.88
81,393.80
73,951.36
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
785.04
719.58
986.94
817.75
1,130.83
1,122.62
1,266.49
Selling and Distribution Expenses
1,36,884.91
1,36,902.50
1,52,818.13
1,28,267.57
1,18,266.82
1,14,462.64
1,41,985.49
Other Expenses
-11,146.74
-9,907.85
-7,572.28
-9,321.42
-8,998.57
-8,251.64
-7,521.79
Total Expenditure (Excl Depreciation)
3,72,071.38
3,52,873.66
4,17,532.32
3,49,961.22
3,41,460.85
3,13,001.50
3,87,877.91
Operating Profit (PBDIT) excl Other Income
102465.59999999999
88171.4
60368.6
82857.09999999999
91589.59999999999
70777.2
56617.399999999994
Other Income
5,419.91
8,094.08
11,420.72
6,351.02
-3,692.91
9,522.34
12,198.41
Operating Profit (PBDIT)
1,21,005.79
1,08,657.71
83,982.42
1,01,306.38
99,899.37
92,085.23
80,158.74
Interest
785.04
719.58
986.94
817.75
1,130.83
1,122.62
1,266.49
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
2,39,350.55
2,25,073.90
2,13,186.71
2,11,124.68
2,09,856.46
1,85,239.80
1,98,602.86
Depreciation
13,120.24
12,392.23
12,193.12
12,098.26
12,002.65
11,785.73
11,342.97
Profit Before Tax
1,07,100.52
95,545.90
70,802.36
88,390.37
86,765.90
79,176.89
67,549.28
Tax
16,764.02
14,536.64
10,180.29
13,369.58
14,374.17
12,029.53
8,397.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
90,336.50
81,009.26
60,622.07
75,020.80
72,391.73
67,147.35
59,152.04
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
90,336.50
81,009.26
60,622.07
75,020.80
72,391.73
67,147.35
59,152.04
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
90,336.50
81,009.26
60,622.07
75,020.80
72,391.73
67,147.35
59,152.04
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
16,38,930.91
17,33,171.83
16,61,140.82
16,36,988.86
15,69,291.12
14,92,105.10
14,32,841.54
Earnings per share (EPS)
965.61
865.91
647.99
801.9
967.24
717.74
632.27
Diluted Earnings per share
965.61
865.91
647.99
801.9
967.24
717.74
632.27
Operating Profit Margin (Excl OI)
21.59%
19.99%
12.63%
19.14%
21.15%
18.44%
12.74%
Gross Profit Margin
25.33%
24.47%
17.37%
23.22%
22.81%
23.7%
17.75%
PAT Margin
19.04%
18.37%
12.69%
17.33%
16.72%
17.5%
13.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 7.59% vs -7.71% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 11.51% vs 33.63% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 14.94% vs 38.59% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 9.09% vs -27.08% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Binh Dinh Pharmaceutical & Medical Equipment JSC With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
4,74,537.02
6,32,695.78
-1,58,158.76
-25.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,74,537.02
6,32,695.78
-1,58,158.76
-25.00%
Raw Material Cost
2,35,186.46
3,81,185.96
-1,45,999.50
-38.30%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
1,10,682.36
54,467.17
56,215.19
103.21%
Power Cost
0
0
0.00
Manufacturing Expenses
785.04
6,177.51
-5,392.47
-87.29%
Selling and Distribution Expenses
1,36,884.91
1,35,328.51
1,556.40
1.15%
Other Expenses
-11,146.74
-6,064.47
-5,082.27
-83.80%
Total Expenditure (Excl Depreciation)
3,72,071.38
5,16,514.48
-1,44,443.10
-27.96%
Operating Profit (PBDIT) excl Other Income
1,02,465.64
116,181.30
-13,715.66
-11.81%
Other Income
5,419.91
4,850.46
569.45
11.74%
Operating Profit (PBDIT)
1,21,005.79
1,47,321.04
-26,315.25
-17.86%
Interest
785.04
6,177.51
-5,392.47
-87.29%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
2,39,350.55
2,51,509.82
-12,159.27
-4.83%
Depreciation
13,120.24
26,289.28
-13,169.04
-50.09%
Profit Before Tax
1,07,100.52
1,14,854.25
-7,753.73
-6.75%
Tax
16,764.02
24,558.69
-7,794.67
-31.74%
Provisions and contingencies
0
0
0.00
Profit After Tax
90,336.50
72,642.95
17,693.55
24.36%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
90,336.50
72,642.95
17,693.55
24.36%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
90,336.50
72,642.95
17,693.55
24.36%
Equity Capital
0
0
0.00
Face Value
10,000.00
10,000.00
0.00
Reserves
16,38,930.91
21,22,140.85
-4,83,209.94
-22.77%
Earnings per share (EPS)
965.61
471.68
493.93
104.72%
Diluted Earnings per share
965.61
471.68
493.93
104.72%
Operating Profit Margin (Excl OI)
21.59%
18.36%
0.00
3.23%
Gross Profit Margin
25.33%
22.31%
0.00
3.02%
PAT Margin
19.04%
11.48%
0.00
7.56%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 47,453.70 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 7.59% vs -7.71% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 9.58% vs 4.58% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 9,033.65 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 11.51% vs 33.63% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 24.79% vs 0.78% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11,558.59 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 14.94% vs 38.59% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 11.58% vs 7.27% in Jun 2024

Quarterly - Interest
Interest 78.50 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 9.09% vs -27.08% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -30.58% vs -60.21% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.59%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024